Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-66853366 |
| Mobile: | 13670046396 |
| E-mail: | orders@qcsrm.com |
| QQ: | 2851296956 |
| Skype: | Chat Now! |
| Address: | B1-203 & B3-402 Life Science Park SCT Creative Factory, Pingshan District ShenZhen, China |
| Product Name | MF | CAS | Details |
|---|
| Gabapentin EP Impurity B | C9H13NO2 | 133481-09-1 | Details |
| Gabapentin EP Impurity A | C9H15NO | 64744-50-9 | Details |
| Gabapentin Impurity 14 | C18H32N2O3 | 1083246-63-2 | Details |
| Gabapentin Impurity 14 | C10H17NO3 | 99189-60-3 | Details |
| Glucosamine | C6H13NO5 | 3416-24-8 | Details |
| Gadobutrol Impurity 12 | C6H18N4 | 112-24-3 | Details |
| Gcle | C24H23ClN2O5S | 104146-10-3 | Details |
| Glucosamine EP Impurity B | C12H20N2O8 | 13185-73-4 | Details |
| Gadobutrol Impurity 37 | C10H22N4O2 | 170454-90-7 | Details |
| Gadobutrol Impurity 54 | C4H9ClO3 | 87032-72-2 | Details |
| Gadobutrol Impurity 16 | C5H12O2 | 77-76-9 | Details |
| Glucosamine EP Impurity C | C12H20N2O7 | 17460-13-8 | Details |
| Glucosamine Impurity 6; Ascorbic Acid EP Impurity A; Sodium Ascorbate EP Impurity A | C5H4O2 | 98-01-1 | Details |
| Gadobutrol EP Impurity A | C20H40N4O10 | 2514736-58-2 | Details |
| Gadobutrol Impurity 41 | C14H26N4O6 | 114873-37-9 | Details |
| Gadobutrol Impurity 38 | C12H24N4O4 | 112193-75-6 | Details |
| Gadobutrol Impurity 35 | C16H28N4O8 | 60239-18-1 | Details |
| Gabapentin EP Impurity E | C9H14O4 | 67950-95-2 | Details |
| Gabapentin EP Impurity D | C18H29NO3 | 1076198-17-8 | Details |
| Gemfibrozil EP Impurity A;Metacresol EP Impurity G | C8H10O | 95-87-4 | Details |
| Gentamicin Sulfate EP Impurity B | C13H27N3O6 | 49751-51-1 | Details |
| Gentamicin Sulfate EP Impurity E(2-Deoxystreptamine) | C6H14N2O3 | 2037-48-1 | Details |
| Gefitinib Impurity 54 | C16H13ClFN3O2 | 153437-78-6 | Details |
| Gefitinib EP Impurity A | C16H21N3O4 | 199327-61-2 | Details |
| Gefitinib EP Impurity B HCl | C22H24ClFN4O3 | 1603814-04-5 | Details |
| Gefitinib Impurity 11 | C21H22ClFN4O3 | 847949-49-9 | Details |
| Gefitinib Impurity F | C29H37ClFN5O4 | 1502829-45-9 | Details |
| Gefitinib Impurity 1 | C22H24ClFN4O4 | 847949-51-3 | Details |
| Gefitinib Intermediate 6 | C17H13ClFN3O3 | 788136-89-0 | Details |
| L-Lysine, (2S)-2-hydroxybutanedioate | C9H9Cl2N3O.ClH | 29110-48-3 | Details |
| Ganciclovir Bisvaline Ester DiHCl | C19H31N7O6 | 130914-71-5 | Details |
| Gastrodin Impurity 7 | C21H24O11 | 31873-42-4 | Details |
| Griseofulvin-d3 | C17H17ClO6 | 126-07-8 | Details |
| Glipizide EP Impurity B;Sodium Cyclamate EP Impurity C | C6H13N | 108-91-8 | Details |
| Glipizide Impurity 34 | C7H11NO | 3173-53-3 | Details |
| Gemcitabine Impurity 34 | C5H6F2O4 | 95058-77-8 | Details |
| Gemcitabine Impurity 18 | C10H16F2O5 | 928797-50-6 | Details |
| Gemcitabine Impurity 19 | C19H14F2O6 | 122111-01-7 | Details |
| Gemcitabine Impurity 20 | C19H16F2O6 | 1173824-58-2 | Details |
| Glycopyrrolate Impurity 34 | C13H15ClO3 | 92021-41-5 | Details |
| Ibuprofen Impurity 71 | C10H11N3O3 | 123704-98-3 | Details |
| Glycyrrhizic Acid Impurity 3 | C42H65NO16 | 80287-34-9 | Details |
| Gliclazide Impurity 18 | C7H9NO2 | 5763-44-0 | Details |
| Gefitinib Impurity 32 | C15H21N3O6 | 861453-16-9 | Details |
| Gefitinib Impurity 29 | C15H19N3O5 | 1006378-06-8 | Details |
| Gefitinib Impurity 18 | C15H23N3O4 | 246512-44-7 | Details |
| Gefitinib Impurity 34 | C6H5Cl2N | 95-76-1 | Details |
| Gefitinib Impurity 14 | C20H22ClFN4O3 | 847949-56-8 | Details |
| Gimeracil Impurity 14 | C8H7NO | 89942-45-0 | Details |
| Ganciclovir EP Impurity A | C9H10ClN5O2 | 1797982-93-4 | Details |
| Ganciclovir EP Impurity B | C12H17N5O5 | 194159-18-7 | Details |
| Ganciclovir EP Impurity C | C9H12ClN5O3 | 108436-36-8 | Details |
| Ganciclovir EP Impurity D | C10H15N5O5 | 1346598-14-8 | Details |
| Ganciclovir EP Impurity E | C9H13N5O4 | 86357-09-7 | Details |
| Ganciclovir EP Impurity F; Valaciclovir EP Impurity A; Aciclovir EP Impurity B | C5H5N5O | 73-40-5 | Details |
| Glipizide EP Impurity G | C16H18N4O5S | 33288-74-3 | Details |
| Glycoursodeoxycholic Acid | C26H43NO5 | 64480-66-6 | Details |
| Glycodeoxycholic Acid Ethyl Ester | C28H47NO5 | 70779-06-5 | Details |
| Gemcitabine EP Impurity C | C9H10F2N2O5 | 114248-23-6 | Details |
| Glutathione Impurity 19 | C10H17N3O8S | 17297-99-3 | Details |
| Guaifenesin EP Impurity D | C17H20O5 | 16929-60-5 | Details |
| Gliclazide EP Impurity E | C15H19N3O3S | 1808087-53-7 | Details |
| Glycopyrronium Bromide EP Impurity L | C14H18O3 | 19833-96-6 | Details |
| Glycopyrronium Bromide EP Impurity M | C12H14O | 5422-88-8 | Details |
| Gliclazide Impurity 14 | C8H10N2O3S | 39051-77-9 | Details |
| Glipizide EP Impurity E | C21H27N5O4S | 66375-96-0 | Details |
| Glipizide EP Impurity D | C14H16N4O3S | 1346600-54-1 | Details |
| Glycocholic Acid Ethyl Ester | C28H47NO6 | 517904-33-5 | Details |
| H-Gly-Gly-Gln-Oh | C9H16N4O5 | 186787-32-6 | Details |
| Glimepiride EP Impurity C | C18H23N3O6S | 119018-30-3 | Details |
| Glycohyodeoxycholic Acid | C26H43NO5 | 13042-33-6 | Details |
| Gliclazide EP Impurity F | C15H21N3O3S | 1076198-18-9 | Details |
| Gliclazide EP Impurity B | C7H12N2O | 54786-86-6 | Details |
| Gliclazide D4 | C15H21N3O3S | 1185039-30-8 | Details |
| Glipizide Impurity 3 | C8H12N2O2S | 933705-21-6 | Details |
| Granisetron EP Impurity D | C9H8N2O2 | 50890-83-0 | Details |
| Granisetron EP Impurity F | C18H24N4O | 1364914-39-5 | Details |
| Granisetron Impurity 11 | C9H9N3O | 129137-93-5 | Details |
| D-Glucuronic Acid | C6H10O7 | 6556-12-3 | Details |
| Glucaric Acid | C6H10O8 | 87-73-0 | Details |
| Glycopyrronium Bromide EP Impurity N Bromide | C19H28BrNO3 | 58493-54-2 | Details |
| Glycopyrrolate Impurity 43 | C13H14O3 | 1404453-64-0 | Details |
| Glycopyrronium Bromide EP Impurity G | C18H25NO3 | 13118-11-1 | Details |
| Glycopyrronium Bromide EP Impurity H; Glycopyrronium EP Impurity H | C9H8O3 | 15206-55-0 | Details |
| Guaifenesin; Ranolazine Hydrochloride Impurity F | C10H14O4 | 93-14-1 | Details |
| Guaifenesin EP Impurity C | C20H26O7 | 1797132-23-0 | Details |
| Guaifenesin EP Impurity B | C10H14O4 | 14007-09-1 | Details |
| Guaiacol; Guaifenesin EP Impurity A | C7H8O2 | 90-05-1 | Details |
| Glutathione EP Impurity A | C5H10N2O3S | 19246-18-5 | Details |
| Gatifloxacin Impurity I | C18H19F2N3O3 | 103460-89-5 | Details |
| Gatifloxacin Despropylene Impurity | C16H18FN3O4 | 172426-86-7 | Details |
| Gatifloxacin Desethylene Impurity | C17H20FN3O4 | 172426-87-8 | Details |
| Gatifloxacin USP Impurity E | C19H22FN3O4 | 1029364-65-5 | Details |
| Gatifloxacin USP Impurity D | C18H20FN3O4 | 112811-57-1 | Details |
| Gatifloxacin Impurity B; Moxifloxacin Impurity 81 | C13H9F2NO4 | 154093-72-8 | Details |
| Gatifloxacin USP Impurity A | C18H20FN3O4 | 616205-76-6 | Details |
| Dapagliflozin Impurity 44 | C16H22O11 | 604-69-3 | Details |
| Ganciclovir EP Impurity I | C15H21N5O6 | 86357-20-2 | Details |
| Ganciclovir EP Impurity H | C9H13N5O4 | 84222-50-4 | Details |
| Ganciclovir EP Impurity J | C18H25N5O7 | 177216-32-9 | Details |
| Product Total： Product Page： | ||||
| 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 | ||||